SCYNEXIS, Inc. Share Price
NASDAQ: SCYX | Micro CapSCYNEXIS, Inc. Stock Performance
SCYNEXIS, Inc. Share Price Today
As of 30 October 2026, SCYNEXIS, Inc.'s share price is $3.87. The stock opened at $3.91, compared to its previous close of $3.91. During today's trading session, SCYNEXIS, Inc.'s share price traded between $3.73 and $3.91, with an average price of $3.82. Over the past 52 weeks, the stock has recorded a high of $6.01 and a low of $0.57. In terms of performance, SCYNEXIS, Inc.'s share price has risen by 314.79% over the last six months and is up 486.36% on a year-on-year basis.
SCYNEXIS, Inc. Share Price Chart
SCYNEXIS, Inc. Quarterly Profit & Loss
All figures in USD
SCYNEXIS, Inc. Annual Profit & Loss
All figures in USD
About SCYNEXIS, Inc.
SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.
SCYNEXIS, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $5.14 | $3.82 | -22.98% |
Sep 2026 | $5.25 | $4.96 | -9.82% |
Aug 2026 | $4.81 | $5.50 | +12.47% |
Jul 2026 | $4.13 | $4.89 | +20.62% |
Jun 2026 | $5.26 | $4.05 | +471.79% |
May 2026 | $0.94 | $0.71 | -24.01% |
Apr 2026 | $0.89 | $0.93 | +2.53% |
Mar 2026 | $0.74 | $0.91 | +22.15% |
Feb 2026 | $0.70 | $0.74 | +4.78% |
Jan 2026 | $0.63 | $0.71 | +13.94% |
Dec 2025 | $0.67 | $0.62 | -11.74% |
Nov 2025 | $0.64 | $0.71 | +7.12% |